Archive for August 2014
“Operation Pangea VI: combating sale of unapproved medicines.” WHO Drug Information 27, no. 3 (September 2013): 227.
Abstract: The article reports on a 2013 decision which the U.S. Food and Drug Administration and several other international law enforcement and regulatory agencies made to take legal and regulatory action against more than 9,600 web sites from various countries that illegally market unproven prescription drugs to consumers. "Operation Pangea VI: combating sale of unapproved…
[...]Ganor, Boaz, and Miri Halperin Wernli. “The Infiltration of Terrorist Organizations Into the Pharmaceutical Industry: Hezbollah as a Case Study.” Studies In Conflict & Terrorism 36, no. 9 (September 2013): 699-712.
Abstract: Criminal syndicates and terrorist organizations are inherently different, one motivated by profit and the other by political goals. Yet their difference enables them to cooperate for their mutual benefit. Nowhere has this been more evident than in the drug trade; from harvesting and trafficking in illegal substances, it has been an easy transition to counterfeiting…
[...]Mackey, Tim K.*, and Bryan A. Liang*. “Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health.” Globalization & Health 9, no. 1 (November 2013): 1-21.
BackgroundDigital forms of direct-to-consumer pharmaceutical marketing (eDTCA) have globalized in an era of free and open information exchange. Yet, the unregulated expansion of eDTCA has resulted in unaddressed global public health threats. Specifically, illicit online pharmacies are engaged in the sale of purportedly safe, legitimate product that may in fact be counterfeit or substandard. These…
[...]Glass, Beverley D. “Counterfeit drugs and medical devices in developing countries.” Research & Reports In Tropical Medicine 5, (March 2014): 11-22.
Abstract: The World Health Organization has reported that counterfeit medicines potentially make up more than 50% of the global drug market, with a significant proportion of these fake products being encountered in developing countries. This occurrence is attributed to a lack of effective regulation and a weak enforcement capacity existing in these countries, with an…
[...]Binkowska-Bury, Monika, et al. “Counterfeit medicines in Poland: opinions of primary healthcare physicians, nurses and lay persons.” Journal Of Clinical Nursing 22, no. 3/4 (February 2013): 559-568.
Aims and objectives. To gain information concerning disparities in the understanding of the counterfeit medicines phenomenon between healthcare workers and lay persons. Background. Central-eastern Europe is facing significant challenges in combating a multi-billion euro, and often lethal, trade in counterfeit medicines. It is a major challenge especially for primary healthcare workers to expand the understanding…
[...]